Sign in | Register
Home | My Space | Post
Topic: Sun Pharma - Follow Stock
Post your View/Query
Rated | Active | Top Boarders
(2 replies) 2 hrs ago
I am in huge loss.. this stock is testing my patience... waste of time and money .. ...
  tilak_2020   0 followers
(1 replies) 2 hrs ago
Stock market sabse bakwass hai...
  rajesh8565   0 followers
(1 replies) 2 hrs ago
Very heartbreaking to see price of sun getting thrashed every day. may be this is the time to start accumulate slowly. got struck 100 at 1000. have faith on sun. lets see....
  s4souma   0 followers
(1 replies) 2 hrs ago
What is the target for 1 year.i am accumulating at every level....
  sachingupta2504   1 followers
(4 replies) 2 hrs ago
...because the shanghvi and valia family are screwing the entire population that trusted them as honest.....they are, in reality, looters and (b)astards!...
  seacal   47 followers

Moneycontrol Sentifi Top themes and market attention on

(2 replies) 2 hrs ago
  parvathyki04   1 followers
(1 replies) 2 hrs ago
Avarage karo aur kou upay nahi...
  anitsadariyau   0 followers
(1 replies) 2 hrs ago
Don`t expect anything from result. glenmark is a perfect example.. max 1 rs dividend.. woh gareebo ko bheek milti hai na. ghatiya stock.. ...
  CRJ78   4 followers
(1 replies) 2 hrs ago
I just say 550 is nrxt target then 500...buy call initiate at 550 rs..no hurry...
  Michael Chan   0 followers
 Posted via mobile
(1 replies) 2 hrs ago
Buy buy buy...
  Guest   713 followers
 Posted via mobile
« First « Prev   2 | 3 | 4   Next »
  • Name*

  • Email*

  • Contact No.*

  • City

Interested in

  • Both

Confused? use our Compare Brokers feature.

Thank you for registering.

Respective broker representative will reach you shortly.

Six months of demonetisation: Has it been a success? 42 comments
Stock Boarder Message
Active Topics
Just Posted | index | SpiceJet | Divis Labs | MMTC Ltd
Explore all topics
Boarder of the Day
amateurinvestor (26412 messages | 2207 followers)
Moneycontrol Home
Font Size: S M L
Customer Support
© 2017 a Web18 Venture